<DOC>
	<DOCNO>NCT00166166</DOCNO>
	<brief_summary>The purpose study elucidate role Endothelium-Derived Hyperpolarizing Factor ( EDHF ) play dilate blood vessel whether differs healthy people high cholesterol . A second purpose study determine identity EDHF .</brief_summary>
	<brief_title>Endothelial Hyperpolarization Humans</brief_title>
	<detailed_description>The vascular endothelium synthesize least four potent vasodilator substance : nitric oxide ( NO ) , prostacyclin , carbon monoxide endothelium-derived hyperpolarizing factor ( EDHF ) contribute vasodilator tone , inhibition platelet activation inflammation . EDHF release stimulate receptor-dependent agonist acetylcholine bradykinin ( BK ) , lead hyperpolarization underlie smooth muscle cell presumably open Ca2+-activated K+ channel . Indirect pharmacological evidence suggest EDHF cytochrome P450-derived arachidonic acid metabolite , presumably epoxide . Although pivotal role NO conduit vessel dilation response acute increase shear stress well know , ' contribution dilation sustain increase flow minimal , may due EDHF release .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<mesh_term>omega-N-Methylarginine</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<mesh_term>Nitroprusside</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<mesh_term>Tetraethylammonium</mesh_term>
	<criteria>Hyperlipidemic ( LDL &gt; 140 ) Healthy Volunteer Pregnancy Diabetes mellitus Cardiovascular Disease Hypertension Use regular medication Renal insufficiency Smoking ( current within past 5 year ) Bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>hyperlipidaemia</keyword>
	<keyword>EDHF</keyword>
	<keyword>FMD</keyword>
</DOC>